Advertisement

Topics

Samsung Bioepsis, Takeda to Work On Multiple Novel Biologic Therapies

15:06 EDT 21 Aug 2017 | Drug Discovery Development

The two companies will immediately begin working on the program’s first therapeutic candidate, TAK-671, which is intended to treat severe acute pancreatitis.
Contributed Author: 
Samsung Bioepsis
Topics: 

Original Article: Samsung Bioepsis, Takeda to Work On Multiple Novel Biologic Therapies

NEXT ARTICLE

More From BioPortfolio on "Samsung Bioepsis, Takeda to Work On Multiple Novel Biologic Therapies"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...